FR2712888B1 - Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci. - Google Patents

Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci.

Info

Publication number: FR2712888B1
Authority: FR; France
Prior art keywords: prodrugs; alkylglucopyranosides; precursors; crossing; alpha
Prior art date: 1993-11-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR9313994A

Other languages

English (en)

Other versions

FR2712888A1 (fr

Inventor

Jean Franck Pierre Louis Fabre

Francois Marie Bernard Paul

Pierre Frederic Emmanue Monsan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bioeurope

Original Assignee

Bioeurope

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-23

Filing date

1993-11-23

Publication date

1996-02-09

1993-11-23 Application filed by Bioeurope filed Critical Bioeurope

1993-11-23 Priority to FR9313994A priority Critical patent/FR2712888B1/fr

1994-11-22 Priority to PCT/FR1994/001363 priority patent/WO1995014705A1/fr

1995-06-02 Publication of FR2712888A1 publication Critical patent/FR2712888A1/fr

1996-02-09 Application granted granted Critical

1996-02-09 Publication of FR2712888B1 publication Critical patent/FR2712888B1/fr

2013-11-23 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids

FR9313994A 1993-11-23 1993-11-23 Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci. Expired - Fee Related FR2712888B1 (fr)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
FR9313994A FR2712888B1 (fr)	1993-11-23	1993-11-23	Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci.
PCT/FR1994/001363 WO1995014705A1 (fr)	1993-11-23	1994-11-22	UTILISATION DE α-D-ALKYLGLUCOPYRANOSIDES ET ESTERS DE CEUX-CI POUR LA PREPARATION DE PRODROGUES CAPABLES DE TRAVERSER LA BARRIERE HEMATO-ENCEPHALIQUE, PRODROGUES ET PRECURSEURS DE CELLES-CI

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9313994A FR2712888B1 (fr)	1993-11-23	1993-11-23	Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci.

Publications (2)

Publication Number	Publication Date
FR2712888A1 FR2712888A1 (fr)	1995-06-02
FR2712888B1 true FR2712888B1 (fr)	1996-02-09

Family

ID=9453140

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9313994A Expired - Fee Related FR2712888B1 (fr)	1993-11-23	1993-11-23	Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci.

Country Status (2)

Country	Link
FR (1)	FR2712888B1 (fr)
WO (1)	WO1995014705A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19524515A1 (de) *	1995-07-05	1997-01-09	Deutsches Krebsforsch	Saccharid-Konjugate
FR2768630B1 (fr) *	1997-09-22	2000-08-04	Ulice Sa	Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires
DE69808017T2 (de)	1997-10-31	2003-04-30	Hoffmann La Roche	D-Prolinderivate
JP5328183B2 (ja) *	2008-03-17	2013-10-30	国立大学法人長崎大学	グルコシドエステル誘導体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4034083A (en) *	1975-11-03	1977-07-05	The Procter & Gamble Company	Compositions for inhibiting absorption of cholesterol
US4939174A (en) *	1988-02-26	1990-07-03	Shashoua Victor E	Appetite suppression with dopamine-fatty acid conjugates
EP0413307A1 (fr) *	1989-08-15	1991-02-20	Lion Corporation	Procédé de fabrication de saccharides mono-estérifiés par des acides gras
FR2676058B1 (fr) *	1991-04-30	1994-02-25	Hoechst Lab	Prodrogues glycosylees, leur procede de preparation et leur utilisation dans le traitement des cancers.
JPH0543428A (ja) *	1991-08-13	1993-02-23	Lion Corp	化粧料

1993
- 1993-11-23 FR FR9313994A patent/FR2712888B1/fr not_active Expired - Fee Related
1994
- 1994-11-22 WO PCT/FR1994/001363 patent/WO1995014705A1/fr active Application Filing

Also Published As

Publication number	Publication date
WO1995014705A1 (fr)	1995-06-01
FR2712888A1 (fr)	1995-06-02

Similar Documents

Publication	Publication Date	Title
NO954694D0 (no)	1995-11-21	Doseringsform for antidepressiva
NL194779B (nl)	2002-11-01	Gestabiliseerd vrijdragend patiÙnttafelstelsel.
NO911591L (no)	1991-10-24	Fremgangsmaate for fremstilling av sukrose-6-ester.
FI932655A (fi)	1993-12-12	Imidatderivat av farmaceutiskt anvaendbara antikonvulsiva sulfamat
FR2712666B1 (fr)	1997-04-04	Luminaire pour application médicale.
FR2708206B1 (fr)	1995-10-06	Administrateur de médicaments pour enfants.
FR2714594B3 (fr)	1996-01-12	Structure de diffuseur pour infusion de plantes médicinales.
FI930882A0 (fi)	1993-02-26	Farmaceutiska foereningar
AU1920595A (en)	1995-09-04	Ranitidine solid dosage form
AU4133997A (en)	1998-04-02	Pharmaceutical composition for the treatment of syndrome x of reaven
FR2708201B1 (fr)	1995-10-20	Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
ITRM920915A0 (it)	1992-12-21	Procedimento per la preparazione di l-(-)- carnitina a partire da un prodotto di scarto avente opposta configurazione.
FI931251A (fi)	1993-09-25	Farmaceutiska foereningar
NO932850L (no)	1994-02-14	Fremgangsmaate for fremstilling av staal
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
FR2712888B1 (fr)	1996-02-09	Utilisation de alpha-D-alkylglucopyranosides et esters de ceux-ci pour la préparation de prodrogues capables de traverser la barrière hématoencéphalique, prodrogues obtenues et précurseurs de celles-ci.
NO911274D0 (no)	1991-03-27	Fremgangsmaate ved sproeytebetong.
ITRM930226A0 (it)	1993-04-08	Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
MX9200018A (es)	1992-07-01	Procedimento para la preparacion de esteres de sulfoxido de 3- exometilencefam.
AU6774694A (en)	1994-11-21	Taste-masking pharmaceutical compositions and methods for making the same
FR2715656B1 (fr)	1996-03-22	Procédé de préparation d'anhydride citraconique.
FR2714603B1 (fr)	1996-03-22	Composition dermatologique et son utilisation pour la préparation d'un médicament.
FR2688117B1 (fr)	1995-05-05	Bloc-moule pour la fabrication de fromages.
FI952377A (fi)	1995-07-11	Farmaseuttisia ibuprofeenikoostumuksia
FR2710447B1 (fr)	1995-11-10	Structure d'isolement pour câble.

Legal Events

Date	Code	Title	Description
2009-09-11	ST	Notification of lapse	Effective date: 20090731